Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Comparison of BR-TND and Viread in Healthy Males
NCT02920931Phase 1Completed
- Sponsor
- Boryung
- Start
- Feb 2016
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tenofovir disoproxil fumarate in hepatitis B (HBV) (2 arms), sponsored by Boryung. Primary endpoints: Maximum Observed Concentration and Area Under the Curve to last measurable time. Started Feb 2016; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02920931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02920931.